ClinicalTrials.gg
RecruitingNCT07229963Updated Sep 24, 2026

Exercise Intensity and Postprandial Effects of Breaking Sedentary Behavior in Overweight Adults

An interventional study of Aerobic Exercise Intervention and Sprint Exercise Intervention in Cardiovascular Risk Markers, Postprandial Metabolism and Exercise Physiology, sponsored by Hacettepe University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 30 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-24.

Primary conditionSedentary BehaviorRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Sedentary Behavior
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's title name Sedentary Behavior.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Hacettepe University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
30 Years to 45 Years
Sex
All
01

Study summary

The purpose of this study is twofold: (1) to determine whether breaking up prolonged sitting with aerobic or sprint cycling breaks reduces postprandial blood glucose, insulin, CRP, and blood pressure, which are established risk markers for cardiometabolic diseases; and (2) to assess substrate oxidation during this period in order to identify which exercise condition promotes the greatest increase in fat oxidation.

Read the detailed description

Sedentary behavior (SED) refers to activities such as sitting, lying down, or reclining that require energy expenditure of ≤1.5 MET during the time spent awake. Prolonged and continuous sedentary behavior leads to adverse effects such as abnormal postprandial metabolic responses, insulin resistance, vascular dysfunction, high blood pressure, increased carbohydrate oxidation, and inflammation. Epidemiological data also show that SED increases the risk of mortality, cardiovascular disease, type 2 diabetes, and certain types of cancer. Experimental studies have shown that 2-5 minutes of low- or moderate-intensity aerobic exercise performed every 20-30 minutes during the postprandial period improves cardiometabolic health by reducing glucose, insulin, and blood pressure during the postprandial period. On the other hand, it is known that short-term sprint interval exercise (SIE) increases insulin sensitivity by rapidly depleting muscle glycogen, improves glucose control, lowers blood pressure, and increases fat oxidation. With these effects, SIE may be a time-efficient method for interrupting SED. Although the cardiometabolic benefits of SIE and aerobic exercise interruptions (AEI) are known, there is a lack of studies comparing the effects of interrupting SED with these two exercise types of different intensities in preventing postprandial cardiometabolic dysfunction. In this context, the aim of the study is to compare the postprandial cardiometabolic effects of interrupting sedentary behavior with AIE and sprint exercise interruptions (SEI) in overweight but otherwise healthy women and men aged 30-45. In this randomized crossover trial, volunteers will participate in three trials: 1) AEI, 2) SEI, and 3) SED. There will be a minimum 4-day washout period between trials. In the SEI and AEI trials, exercise interruptions will be implemented every 30 minutes during the 7-hour sitting period, whereas in the SED trial, participants will remain seated continuously for the entire duration. In all conditions, two meals (breakfast and lunch) will be served 3 hours apart, and the trials will begin, after the breakfast meal is consumed. Venous blood samples for every 30 minutes of the first two hours following meals to measure glucose and to be taken hourly during the rest experiment will be used to analyze insulin, glucose, and C-reactive protein (CRP) levels. In addition, blood pressure will be measured hourly, and fat oxidation will be assessed at the baseline, 2nd, 5th, and 7th hours. The effects of the conditions on glucose and insulin will be evaluated using linear mixed models. A Two-Way (Trial x Number of Repeats) Analysis of Variance for Repeated Measures will be used to detect differences between conditions.

02

Conditions studied

  • Cardiovascular Risk Markers
  • Postprandial Metabolism
  • Exercise Physiology
  • Substrate Oxidation

Browse trials for

Keywords

  • Exercise
  • Sedentary behavior
  • Cardiometabolic health
  • Postprandial metabolism
  • overweight
03

In context

Sedentary Behavior Reclassified

1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.

This study's planned enrollment of 18 is below the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

Hacettepe University is the lead sponsor of 1,007 studies on the registry; 214 are open to participants now.

Compared within Sedentary Behavior, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
30 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being physically inactive (not doing at least 150 minutes/week of structured exercise).
  • Being sedentary (having a daily sedentary time/day for >7 hours).
  • Having a between 25 and 29.9 kg/m2.
  • Having a history of regular menstrual cycles for female participants.
  • Having medical examination approval.

Exclusion criteria

Exclusion Criteria

  • Taking any acute or chronic medication or supplement that may affect metabolism.
  • Having an acute or chronic illness that limits exercise (musculoskeletal problems, cardiovascular disorders, respiratory problems, etc.).
  • Consuming tobacco products.
  • Meeting 3 or more of the metabolic syndrome criteria (waist circumference of 102 cm or more in men, 88 cm or more in women, triglyceride level of 150 mg/dL or higher, HDL cholesterol level below 40 mg/dL in men and 50 mg/dL in women, blood pressure of 130/85 mmHg or higher, fasting blood glucose level of 100 mg/dL (5.6 mg/L) or higher).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
18 participants (estimated)

Study arms

  • Experimental
    Sedentary: Participants will remain seated for 7 h.

    The sedentary condition will take place in a seated position. During the seated condition, volunteers will be seated at a typical desk chair at an appropriate height with hip and knee angles of \~90° and feet flat on the floor. The seating area will include a standard desk chair, a work desk, and the volunteers' personal laptops. Volunteers will be instructed prior to the visit to avoid behaviors such as fidgeting, excessive leg movements, and crossing their legs to minimize potential extraneous effects.

    Other: Sedentary Behaviour Intervention

  • Experimental
    Breaking up sitting with aerobic exercise interruptions

    The protocol that will interrupt sitting with AEI will involve cycle exercises performed at 50% of Wattmax for 2 minutes. The W and rpm levels corresponding to 50% of Wattmax will be determined using the values recorded during the determination of Wattmax.

    Other: Aerobic Exercise Intervention

  • Experimental
    Breaking up sitting with sprint exercise interruptions

    The protocol that will interrupt sitting with SEI will involve cycle exercises performed at the maximum revolutions per minute achievable within 10 seconds. Immediately (2-3 seconds) before each SEI, volunteers will increase their pedal cadence to the maximum speed they can achieve, after which a pedal load will be applied to the bicycle ergometer and a sprint will be performed against the applied load for 10 seconds. During each sprint, the pedal load will be applied at %200 Wattmax level.

    Other: Sprint Exercise Intervention

Interventions

  • OtherAerobic Exercise Intervention

    In the aerobic exercise condition, participants will perform 2 minutes of moderate-intensity (%50 Wattmax) continuous cycling.

  • OtherSprint Exercise Intervention

    In the sprint condition, participants will complete a 10-second sprint at %200 Wattmax level, as determined during the preliminary test.

  • OtherSedentary Behaviour Intervention

    Participants will remain seated for a total duration of 7 hours. During this period, they will be instructed to minimize excessive movement and will only be permitted to rise from the chair for voiding purposes.

06

What researchers measure

Primary outcomes

  1. Insulin

    Postprandial insulin. Net incremental area under the curve and total area under the curve for each 7 h condition will be calculated for insulin.

    Time frame: 7 hour for each experimental condition

Secondary outcomes

  1. Glucose

    Postprandial glucose. Net incremental area under the curve and total area under the curve for each 7 hour condition will be calculated for glucose.

    Time frame: 7 hour for each experimental condition

  2. CRP

    Postprandial CRP. Net incremental area under the curve and total area under the curve for each 7 h condition will be calculated for CRP.

    Time frame: 7 hour

  3. Substrate oxidation

    Postprandial substrate oxidation. During each experimental visit, for 7 hours, volunteers' respiratory data will be collected using a direct calorimeter with canopy hood in lying position for 10 minutes at 0, 2th, 5th, and 7th hours. The volunteers' resting fat and carbohydrate oxidations will be determined from the obtained data.

    Time frame: 0, 2th, 5th, 7th hours

  4. Blood pressure

    Postprandial arterial blood pressure will be measured hourly for 7 h using an automatic blood pressure monitor with a cuff of appropriate size. The systolic and diastolic BP values measured will be recorded, and the mean arterial pressure will be calculated.

    Time frame: 7 hour

07

Study locations

1 of 1 sites recruiting
  • Hacettepe Sports Science Faculty, Hacettepe Beytepe Clinic
    Ankara, Beytepe, Turkey (Türkiye)
    Recruiting
    • Şükran Nazan Koşar, Professor · Contactnazankosar@gmail.com · 0538 861 29 24
    • Hikmet Sercan Toprakoğlu · Principal investigator
    • Seda Hanife Oğuz Baykal, Associate Professor · Sub investigator
    • Muhammed Mustafa Atakan, Associate Professor · Sub investigator
    • Yasemin Güzel, Doctoral faculty member · Sub investigator
    • Yiğitcan Karanfil, Doctoral faculty member · Sub investigator
    • İbrahim Türkel, Doctoral faculty member · Sub investigator
    • Şükran Nazan Koşar, Professor · Sub investigator
08

References and documents

Publications

  • Compher C, Frankenfield D, Keim N, Roth-Yousey L; Evidence Analysis Working Group. Best practice methods to apply to measurement of resting metabolic rate in adults: a systematic review. J Am Diet Assoc. 2006 Jun;106(6):881-903. doi: 10.1016/j.jada.2006.02.009. PubMed 16720129 ↗
  • Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):628-34. doi: 10.1152/jappl.1983.55.2.628. PubMed 6618956 ↗
  • DeMers D, Wachs D. Physiology, Mean Arterial Pressure. 2023 Apr 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK538226/ PubMed 30855814 ↗
  • Stergiou GS, Palatini P, Parati G, O'Brien E, Januszewicz A, Lurbe E, Persu A, Mancia G, Kreutz R; European Society of Hypertension Council and the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021 Jul 1;39(7):1293-1302. doi: 10.1097/HJH.0000000000002843. No abstract available. PubMed 33710173 ↗
  • Mattes RD, Campbell WW. Effects of food form and timing of ingestion on appetite and energy intake in lean young adults and in young adults with obesity. J Am Diet Assoc. 2009 Mar;109(3):430-7. doi: 10.1016/j.jada.2008.11.031. PubMed 19248858 ↗
  • Augustin LSA, Kendall CWC, Jenkins DJA, Willett WC, Astrup A, Barclay AW, Bjorck I, Brand-Miller JC, Brighenti F, Buyken AE, Ceriello A, La Vecchia C, Livesey G, Liu S, Riccardi G, Rizkalla SW, Sievenpiper JL, Trichopoulou A, Wolever TMS, Baer-Sinnott S, Poli A. Glycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC). Nutr Metab Cardiovasc Dis. 2015 Sep;25(9):795-815. doi: 10.1016/j.numecd.2015.05.005. Epub 2015 May 16. PubMed 26160327 ↗
  • Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser. 2003;916:i-viii, 1-149, backcover. PubMed 12768890 ↗
  • Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990 Feb;51(2):241-7. doi: 10.1093/ajcn/51.2.241. PubMed 2305711 ↗
  • Carrillo-Arango HA, Atencio-Osorio MA, Lopez-Alban CA, Nava-Gonzalez EJ, Correa-Rodriguez M, Izquierdo M, Ramirez-Velez R. Metabolic responses to acute sprint interval exercise training performed after an oral 75-gram glucose load in individuals with overweight/obesity. Physiol Rep. 2023 Jan;11(2):e15555. doi: 10.14814/phy2.15555. PubMed 36695728 ↗
  • Ramirez-Velez R, Carrillo-Arango HA, Atencio-Osorio MA, Lopez-Alban CA, Calderon-Gonzalez JC, Morales-Alamo D, Izquierdo M, Correa-Rodriguez M. No sex differences in systemic metabolic responses to acute sprint interval training performed after an oral 75-g glucose load in adults with excess adiposity. Clin Nutr ESPEN. 2025 Feb;65:25-35. doi: 10.1016/j.clnesp.2024.11.005. Epub 2024 Nov 17. PubMed 39551347 ↗
  • Baker JS, Davies B. Brief high-intensity exercise and resistive force selection in overweight and obese subjects: body mass or body composition? Res Sports Med. 2006 Apr-Jun;14(2):97-106. doi: 10.1080/15438620600651298. PubMed 16869135 ↗
  • Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81. PubMed 7154893 ↗
  • Midgley AW, McNaughton LR, Polman R, Marchant D. Criteria for determination of maximal oxygen uptake: a brief critique and recommendations for future research. Sports Med. 2007;37(12):1019-28. doi: 10.2165/00007256-200737120-00002. PubMed 18027991 ↗
  • Lanzi S, Codecasa F, Cornacchia M, Maestrini S, Salvadori A, Brunani A, Malatesta D. Fat oxidation, hormonal and plasma metabolite kinetics during a submaximal incremental test in lean and obese adults. PLoS One. 2014 Feb 11;9(2):e88707. doi: 10.1371/journal.pone.0088707. eCollection 2014. PubMed 24523934 ↗
  • Tudor-Locke C, Craig CL, Thyfault JP, Spence JC. A step-defined sedentary lifestyle index: <5000 steps/day. Appl Physiol Nutr Metab. 2013 Feb;38(2):100-14. doi: 10.1139/apnm-2012-0235. Epub 2012 Nov 8. PubMed 23438219 ↗
  • Schmidt MD, Cleland VJ, Shaw K, Dwyer T, Venn AJ. Cardiometabolic risk in younger and older adults across an index of ambulatory activity. Am J Prev Med. 2009 Oct;37(4):278-84. doi: 10.1016/j.amepre.2009.05.020. PubMed 19765498 ↗
  • Ekmekcioglu C, Touitou Y. Chronobiological aspects of food intake and metabolism and their relevance on energy balance and weight regulation. Obes Rev. 2011 Jan;12(1):14-25. doi: 10.1111/j.1467-789X.2010.00716.x. PubMed 20122134 ↗
  • Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet. 2005 Sep 24-30;366(9491):1059-62. doi: 10.1016/S0140-6736(05)67402-8. No abstract available. PubMed 16182882 ↗
  • Parolin ML, Chesley A, Matsos MP, Spriet LL, Jones NL, Heigenhauser GJ. Regulation of skeletal muscle glycogen phosphorylase and PDH during maximal intermittent exercise. Am J Physiol. 1999 Nov;277(5):E890-900. doi: 10.1152/ajpendo.1999.277.5.E890. PubMed 10567017 ↗
  • Jensen J, Jebens E, Brennesvik EO, Ruzzin J, Soos MA, Engebretsen EM, O'Rahilly S, Whitehead JP. Muscle glycogen inharmoniously regulates glycogen synthase activity, glucose uptake, and proximal insulin signaling. Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E154-E162. doi: 10.1152/ajpendo.00330.2005. Epub 2005 Aug 23. PubMed 16118249 ↗
  • Derave W, Hansen BF, Lund S, Kristiansen S, Richter EA. Muscle glycogen content affects insulin-stimulated glucose transport and protein kinase B activity. Am J Physiol Endocrinol Metab. 2000 Nov;279(5):E947-55. doi: 10.1152/ajpendo.2000.279.5.E947. PubMed 11052948 ↗
  • Casey A, Constantin-Teodosiu D, Howell S, Hultman E, Greenhaff PL. Metabolic response of type I and II muscle fibers during repeated bouts of maximal exercise in humans. Am J Physiol. 1996 Jul;271(1 Pt 1):E38-43. doi: 10.1152/ajpendo.1996.271.1.E38. PubMed 8760079 ↗
  • Holloszy JO. Exercise-induced increase in muscle insulin sensitivity. J Appl Physiol (1985). 2005 Jul;99(1):338-43. doi: 10.1152/japplphysiol.00123.2005. PubMed 16036907 ↗
  • Devlin JT, Hirshman M, Horton ED, Horton ES. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes. 1987 Apr;36(4):434-9. doi: 10.2337/diab.36.4.434. PubMed 3102297 ↗
  • Gibala MJ, Little JP. Physiological basis of brief vigorous exercise to improve health. J Physiol. 2020 Jan;598(1):61-69. doi: 10.1113/JP276849. Epub 2019 Dec 20. PubMed 31691289 ↗
  • Cochran AJ, Percival ME, Tricarico S, Little JP, Cermak N, Gillen JB, Tarnopolsky MA, Gibala MJ. Intermittent and continuous high-intensity exercise training induce similar acute but different chronic muscle adaptations. Exp Physiol. 2014 May 1;99(5):782-91. doi: 10.1113/expphysiol.2013.077453. Epub 2014 Feb 14. PubMed 24532598 ↗
  • Bogdanis GC, Nevill ME, Lakomy HK, Boobis LH. Power output and muscle metabolism during and following recovery from 10 and 20 s of maximal sprint exercise in humans. Acta Physiol Scand. 1998 Jul;163(3):261-72. doi: 10.1046/j.1365-201x.1998.00378.x. PubMed 9715738 ↗
  • Sabag A, Little JP, Johnson NA. Low-volume high-intensity interval training for cardiometabolic health. J Physiol. 2022 Mar;600(5):1013-1026. doi: 10.1113/JP281210. Epub 2021 Apr 18. PubMed 33760255 ↗
  • Dunstan DW, Kingwell BA, Larsen R, Healy GN, Cerin E, Hamilton MT, Shaw JE, Bertovic DA, Zimmet PZ, Salmon J, Owen N. Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care. 2012 May;35(5):976-83. doi: 10.2337/dc11-1931. Epub 2012 Feb 28. PubMed 22374636 ↗
  • Dey KC, Zakrzewski-Fruer JK, Smith LR, Jones RL, Bailey DP. Interrupting sitting acutely attenuates cardiometabolic risk markers in South Asian adults living with overweight and obesity. Eur J Appl Physiol. 2024 Apr;124(4):1163-1174. doi: 10.1007/s00421-023-05345-7. Epub 2023 Nov 11. PubMed 37950762 ↗
  • Larsen RN, Kingwell BA, Sethi P, Cerin E, Owen N, Dunstan DW. Breaking up prolonged sitting reduces resting blood pressure in overweight/obese adults. Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):976-82. doi: 10.1016/j.numecd.2014.04.011. Epub 2014 May 2. PubMed 24875670 ↗
  • Wongpipit W, Zhang X, Miyashita M, Wong SH. Interrupting Prolonged Sitting Reduces Postprandial Glucose Concentration in Young Men With Central Obesity. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e791-e802. doi: 10.1210/clinem/dgaa834. PubMed 33186451 ↗
  • Peddie MC, Bone JL, Rehrer NJ, Skeaff CM, Gray AR, Perry TL. Breaking prolonged sitting reduces postprandial glycemia in healthy, normal-weight adults: a randomized crossover trial. Am J Clin Nutr. 2013 Aug;98(2):358-66. doi: 10.3945/ajcn.112.051763. Epub 2013 Jun 26. PubMed 23803893 ↗
  • Benatti FB, Ried-Larsen M. The Effects of Breaking up Prolonged Sitting Time: A Review of Experimental Studies. Med Sci Sports Exerc. 2015 Oct;47(10):2053-61. doi: 10.1249/MSS.0000000000000654. PubMed 26378942 ↗
  • Loh R, Stamatakis E, Folkerts D, Allgrove JE, Moir HJ. Effects of Interrupting Prolonged Sitting with Physical Activity Breaks on Blood Glucose, Insulin and Triacylglycerol Measures: A Systematic Review and Meta-analysis. Sports Med. 2020 Feb;50(2):295-330. doi: 10.1007/s40279-019-01183-w. PubMed 31552570 ↗
  • Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, Anfossi G, Costa G, Trovati M. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab. 2006 Mar;91(3):813-9. doi: 10.1210/jc.2005-1005. Epub 2005 Dec 13. PubMed 16352690 ↗
  • Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006 Apr 12;295(14):1681-7. doi: 10.1001/jama.295.14.1681. PubMed 16609090 ↗
  • Pappas C, Kandaraki EA, Tsirona S, Kountouras D, Kassi G, Diamanti-Kandarakis E. Postprandial dysmetabolism: Too early or too late? Hormones (Athens). 2016 Jul;15(3):321-344. doi: 10.14310/horm.2002.1697. PubMed 27838603 ↗
  • O'Keefe JH, Bell DS. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol. 2007 Sep 1;100(5):899-904. doi: 10.1016/j.amjcard.2007.03.107. Epub 2007 Jun 26. PubMed 17719342 ↗
  • Trost SG, Owen N, Bauman AE, Sallis JF, Brown W. Correlates of adults' participation in physical activity: review and update. Med Sci Sports Exerc. 2002 Dec;34(12):1996-2001. doi: 10.1097/00005768-200212000-00020. PubMed 12471307 ↗
  • Akins JD, Crawford CK, Burton HM, Wolfe AS, Vardarli E, Coyle EF. Inactivity induces resistance to the metabolic benefits following acute exercise. J Appl Physiol (1985). 2019 Apr 1;126(4):1088-1094. doi: 10.1152/japplphysiol.00968.2018. Epub 2019 Feb 14. PubMed 30763169 ↗
  • Ekelund U, Steene-Johannessen J, Brown WJ, Fagerland MW, Owen N, Powell KE, Bauman A, Lee IM; Lancet Physical Activity Series 2 Executive Committe; Lancet Sedentary Behaviour Working Group. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet. 2016 Sep 24;388(10051):1302-10. doi: 10.1016/S0140-6736(16)30370-1. Epub 2016 Jul 28. PubMed 27475271 ↗
  • Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, Olson RD. The Physical Activity Guidelines for Americans. JAMA. 2018 Nov 20;320(19):2020-2028. doi: 10.1001/jama.2018.14854. PubMed 30418471 ↗
  • DiPietro L, Al-Ansari SS, Biddle SJH, Borodulin K, Bull FC, Buman MP, Cardon G, Carty C, Chaput JP, Chastin S, Chou R, Dempsey PC, Ekelund U, Firth J, Friedenreich CM, Garcia L, Gichu M, Jago R, Katzmarzyk PT, Lambert E, Leitzmann M, Milton K, Ortega FB, Ranasinghe C, Stamatakis E, Tiedemann A, Troiano RP, van der Ploeg HP, Willumsen JF. Advancing the global physical activity agenda: recommendations for future research by the 2020 WHO physical activity and sedentary behavior guidelines development group. Int J Behav Nutr Phys Act. 2020 Nov 26;17(1):143. doi: 10.1186/s12966-020-01042-2. PubMed 33239105 ↗
  • King WC, Chen JY, Courcoulas AP, Mitchell JE, Wolfe BM, Patterson EJ, Inabnet WB, Dakin GF, Flum DR, Cook B, Belle SH. Objectively-measured sedentary time and cardiometabolic health in adults with severe obesity. Prev Med. 2016 Mar;84:12-8. doi: 10.1016/j.ypmed.2015.12.007. Epub 2015 Dec 24. PubMed 26724517 ↗
  • Honda T, Chen S, Yonemoto K, Kishimoto H, Chen T, Narazaki K, Haeuchi Y, Kumagai S. Sedentary bout durations and metabolic syndrome among working adults: a prospective cohort study. BMC Public Health. 2016 Aug 26;16(1):888. doi: 10.1186/s12889-016-3570-3. PubMed 27562190 ↗
  • Dempsey PC, Biddle SJH, Buman MP, Chastin S, Ekelund U, Friedenreich CM, Katzmarzyk PT, Leitzmann MF, Stamatakis E, van der Ploeg HP, Willumsen J, Bull F. New global guidelines on sedentary behaviour and health for adults: broadening the behavioural targets. Int J Behav Nutr Phys Act. 2020 Nov 26;17(1):151. doi: 10.1186/s12966-020-01044-0. PubMed 33239026 ↗
  • Pinto AJ, Bergouignan A, Dempsey PC, Roschel H, Owen N, Gualano B, Dunstan DW. Physiology of sedentary behavior. Physiol Rev. 2023 Oct 1;103(4):2561-2622. doi: 10.1152/physrev.00022.2022. Epub 2023 Jun 16. PubMed 37326297 ↗
  • Wanner M, Richard A, Martin B, Faeh D, Rohrmann S. Associations between self-reported and objectively measured physical activity, sedentary behavior and overweight/obesity in NHANES 2003-2006. Int J Obes (Lond). 2017 Jan;41(1):186-193. doi: 10.1038/ijo.2016.168. Epub 2016 Sep 28. PubMed 27677618 ↗
  • Prince SA, Elliott CG, Scott K, Visintini S, Reed JL. Device-measured physical activity, sedentary behaviour and cardiometabolic health and fitness across occupational groups: a systematic review and meta-analysis. Int J Behav Nutr Phys Act. 2019 Apr 2;16(1):30. doi: 10.1186/s12966-019-0790-9. PubMed 30940176 ↗
  • Tremblay MS, Aubert S, Barnes JD, Saunders TJ, Carson V, Latimer-Cheung AE, Chastin SFM, Altenburg TM, Chinapaw MJM; SBRN Terminology Consensus Project Participants. Sedentary Behavior Research Network (SBRN) - Terminology Consensus Project process and outcome. Int J Behav Nutr Phys Act. 2017 Jun 10;14(1):75. doi: 10.1186/s12966-017-0525-8. PubMed 28599680 ↗

Individual participant data

Plan to share: No — We do not plan to share IPD with other researchers due to privacy concerns and ethical restrictions outlined in the study's informed consent procedure.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Nov 2026, 2 months after the start.

Of 733 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 2 months is below that.

Counting every sponsor, half of 741 studies reached it within 14 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 24, 2025
First posted
Nov 17, 2025
StartActual
Sep 1, 2026
Primary completionEst.
Nov 20, 2026
CompletionEst.
Dec 15, 2026
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07229963
Responsible party
Muhammed Mustafa Atakan (Associate Professor, Hacettepe University) — Principal investigator
First posted
Nov 17, 2025
Start date
Sep 1, 2026
Primary completion
Nov 20, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Sep 24, 2026

Study contacts

Hikmet Sercan Toprakoğlu
Contact
sercantprkgl@gmail.com
+905369792652
Şükran Nazan Koşar, Professor
principal investigator · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion